Startups

Scientist 3, Discovery Oncology

Genentech · South San Francisco · On-site

← All jobs
About Genentech

Genentech discovers, develops, manufactures and commercializes treatments for patients with serious and life-threatening medical conditions. Backed by North Carolina Biotechnology Center.

About the role

We are seeking a talented and highly motivated Scientist to join our Research Oncology team at Genentech. As a Scientist in this role, you will be critical to delivering on our drug discovery pipeline. You will develop projects and design experiments that yield key mechanistic insights to advance novel therapeutic targets and enable new drug discovery approaches.

More about this role

The Opportunity

We are seeking a talented and highly motivated Scientist to join our Research Oncology team at Genentech. As a Scientist in this role, you will be critical to delivering on our drug discovery pipeline. You will develop projects and design experiments that yield key mechanistic insights to advance novel therapeutic targets and enable new drug discovery approaches.

This position offers the opportunity to collaborate with cross-functional teams and utilize cutting-edge technologies to conduct highly impactful and creative research with the ultimate goal of improving patients’ lives.

Key Responsibilities

Deliver on the pipeline : Design, execute and interpret hypothesis-driven experiments, generate highly reproducible data robust tools and assays to drive oncology drug discovery forward.

Drive scientific discovery : Engage in scientific discussion, stay up to date with the scientific literature in a fast-paced dynamic research environment. Propose new ideas or creative solutions and identify key experiments to yield key mechanistic insights required to pursue and validate therapeutic targets.

Collaborate across functions : Work productively with multidisciplinary teams...

Read the full posting on Genentech's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.